Generic Drugs – Physician Perspective – Thematic Intelligence
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Generic Drugs Thematic Intelligence Report Overview
The report suggests that US physicians prescribed more generic drugs to more than 60% of its patients when compared to their counterparts in the five major European markets (France, Germany, Italy, Spain, and the UK). Italy had the lowest number recorded in the surveyed countries.
Even though physicians and pharmacists play a crucial role in drug choice, patient preferences should not be ignored. When patients have more information about their disease treatment, better outcomes can be achieved.
Many healthcare professionals (HCPs) believe that the adoption of generics will further increase in the next five years because of the growing penetration of generic drugs especially in more advanced markets. Therefore, they support substituting brand-name drugs with generic medicines. HCPs also opine that they would prefer to use branded drugs for their patients if cost was not the main factor.
The ‘generic drugs – physician perspective’ thematic intelligence report assesses the healthcare professionals’ attitudes towards generic drug prescriptions. It gives an understanding of the physician’s perception of generic medicines and the patient’s preferences. The report also explores the physicians’ perception of the use of generic drugs across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
Key Countries | · The US
· France · Germany · Italy · Spain · The UK · Japan |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Generic Drugs – Current and Future Uptake
The US: Many HCPs in the US confirmed that they prescribe generic drugs to more than 61% of their patients. As the demand for drugs is increasing, governments are exerting pressure on doctors to prescribe cheaper generic medicines.
France: French physicians also indicated a strong uptake in generics use during the past five years and expected a further increase in the future. More than 34% of French HCPs reported using generic drugs. Physicians also confirmed the increasing trend in generic drug use during the past five years, and more than 60% of the survey respondents believed that generic uptake would increase in the next five years as well. This is the highest reported number across the surveyed countries.
Generic Drugs – Current and Future Uptake – The US
Buy the Full Report for More Insights on the Current and Future Uptake of Generic Drugs
Generic Drugs – Physician’s Perspective
Physicians’ perceptions can also significantly influence patient choices. The countries covered to know the physician’s perspective towards generic evaluated here include the US, 5EU, and Japan.
Japan: The uptake of generic drugs in Japan has been slower. However, ongoing government initiatives are helping to increase the utilization of generic medicines in this market. A significant percentage of physicians in Japan agreed that patients prefer branded drugs over generics. This common finding across all countries researched suggests that governments and physicians may need to engage more in patient education to address the patients’ misconceptions.
Buy the Full Report for More Insights on the Physician’s Attitude towards Generic Drugs
Scope
The report helps to:
- Assess healthcare professionals’ attitudes towards generic drug prescription.
- Better understand the barriers to the production and uptake of generic medicines.
- Capture physicians’ opinions on generics substitution.
- Better understand patients’ preferences.
- Assess past and future generics uptake.
- Gain a better understanding of cost considerations when prescribing drugs.
- Explore the differences across markets.
Key Highlights
- Generic drugs provide a good opportunity to increase efficiency in pharmaceutical spending.
- Patient and physician education on generics is necessary to boost generics uptake.
- Generic drug penetration has reached its zenith in most of the advanced pharmaceutical markets.
Reasons to Buy
- This report combines information obtained from secondary sources and primary research with physicians from the 7MM, as well as polls with the readers of the Pharmaceutical Technology website.
- It examines physician perception of generic medicines and provides insights into generics uptake, substitution patterns, and use across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- The report highlights the key players in the generic space and includes generics market size as well as growth forecast.
Frequently asked questions
-
Which country’s physicians prescribe more generic drugs?
US physicians were prescribing more generic drugs compared to their counterparts in the five major European markets.
-
Why is the government exerting pressure on doctors to prescribe cheaper generic medicines in the US?
Owing to the rising demand for generic drugs, governments in the US are exerting pressure on doctors to prescribe cheaper generic medicines.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.